Related Experiment Video
Updated: Aug 10, 2026

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Copy task performance and urinary incontinence in Alzheimer's disease
H A Davidson1, M J Borrie, R G Crilly
1Department of Psychology, Parkwood Hospital, London, Ontario.
Journal of the American Geriatrics Society
|May 1, 1991
Summary
Urinary incontinence in Alzheimer's Disease (AD) is linked to specific cognitive deficits, particularly in spatial tasks. This suggests limitations in standard cognitive assessments like the Mini-Mental Status Exam (MMSE) for evaluating dementia severity.
Area of Science:
- Neuroscience
- Gerontology
- Neurology
Background:
- The link between behavioral symptoms and cognitive impairment in Alzheimer's Disease (AD) is not well understood.
- Urinary incontinence is common in AD but its correlation with global cognitive impairment measures is unclear.
Purpose of the Study:
- To investigate the cognitive correlates of urinary incontinence in patients with Alzheimer's Disease.
- To explore the relationship between specific cognitive deficits and urinary incontinence in AD.
Main Methods:
- Retrospective and prospective studies involving patients diagnosed with dementia, probable Alzheimer's Disease.
- Comparison of incontinent AD patients with continent controls matched for age, sex, and Mini-Mental Status Exam (MMSE) scores.
- Assessment of cognitive function using tasks such as cube copying and qualitative analysis of drawings.
Main Results:
- Incontinent AD patients showed significantly poorer performance on a cube copying task compared to continent patients.
- Drawings by incontinent patients exhibited features similar to those seen in patients with right-sided parietal lesions, indicating spatial and perspective difficulties.
- No significant differences were found in age, sex distribution, or overall MMSE scores between incontinent and continent groups.
Conclusions:
- Inability to perform copying tasks, particularly those assessing spatial orientation, is associated with urinary incontinence in AD.
- These findings highlight the limitations of the MMSE in capturing crucial cognitive deficits relevant to functional decline in AD.
- Further research into copying performance and incontinence may elucidate cortical mechanisms of urinary continence and improve dementia assessment.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

